DACT3 and malignant colon neoplasm: There is reduced DACT3 expression in human colon tumors due to histone modifications, resulting in increased Wnt signaling activity; this suppression of DACT3 expression is relieved in colon cancer cell lines by treatment with histone methylation and deacetylase inhibitors [28], [29].